A wide-reaching global review has found that some of the most common pain and fever medicines might increase vulnerability to infections like COVID-19, while others may hold hope for improving our immune response.
Mar 1, 2022
0
6
Encephalitis affects nearly 500,000 people of all ages worldwide each year, according to the Encephalitis Society, with young children and older adults most vulnerable. Other risk factors include having a compromised immune ...
Feb 21, 2022
0
14
The World Health Organization said Friday that it had prequalified the arthritis treatment tocilizumab for use in patients hospitalised with severe COVID-19, in a bid to increase access to the pricey drug.
Feb 11, 2022
0
13
Over-the-counter (OTC) analgesics, such as aspirin, non-steroidal anti-inflammatory drugs (NSAIDS), and acetaminophen, are some of the most commonly used medications, widely available without a prescription, and perceived ...
Feb 9, 2022
0
163
Podophyllum sinense, a folk herbal medicine, possesses multiple phytochemicals and extensive pharmaceutical activities. Modern pharmacological studies have indicated that P. sinense has remarkable activities, such as anti-proliferative, ...
Jan 18, 2022
0
2
A growing body of research suggests that early-life infection, inflammation, and metabolic changes could contribute to psychiatric disorders—perhaps via effects during critical periods of brain development. New evidence ...
Jan 11, 2022
0
44
With summer holidays underway, it's time to think about the sun and your skin. Australia has the highest rate of skin cancer in the world, so we need to be doing more to protect ourselves from the damaging effects of ultraviolet ...
Dec 23, 2021
0
2
In recent years, new drugs to treat multiple sclerosis have significantly improved both the quality of life and longevity for patients with MS. Many of them now live well into their 60s and70s, a significant improvement from ...
Dec 3, 2021
0
30
A research team led by Nicolas Dumont, a researcher at CHU Sainte-Justine and professor at the Université de Montréal, has discovered a new therapeutic molecule, Resolvin-D2. It has the potential to significantly improve ...
Nov 1, 2021
0
58
Scientists from the Trinity Biomedical Sciences Institute (TBSI) have discovered two new ways to block inflammatory macrophages—front-line cells in our immune system that cause complications in a suite of diseases, including ...
Oct 19, 2021
0
14
